Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/29/2025

Treatment of Urethral Discharge Without Pyuria

Diagnostic Approach

  • For patients with urethral discharge but no pyuria, the European Association of Urology recommends performing nucleic acid amplification testing (NAAT) for Neisseria gonorrhoeae and Chlamydia trachomatis on first-void urine or urethral swab, and if symptoms are mild, delay treatment until NAAT results guide pathogen-directed therapy 1
  • The absence of pyuria does not exclude sexually transmitted urethritis, with low sensitivity of urethral swabs and first-catch urine for detecting polymorphonuclear leukocytes for C. trachomatis (29%), Mycoplasma genitalium (50-62%), and Ureaplasma urealyticum (33%) in patients without visible discharge is not a reliable indicator 1

Essential Testing

  • Perform Gram stain of urethral discharge or smear for preliminary diagnosis of gonococcal urethritis (looking for Gram-negative intracellular diplococci), as recommended by the European Urology guidelines 1
  • Obtain validated NAAT on first-void urine or urethral swab before empirical treatment to diagnose both chlamydial and gonococcal infections, as recommended by the European Association of Urology guidelines 1, 2
  • Perform urethral swab culture if NAAT is positive for gonorrhea to assess antimicrobial resistance profiles, as recommended by the European Urology guidelines 1

Treatment Strategy Based on Symptom Severity

  • For patients with mild symptoms, the European Association of Urology guidelines recommend delaying treatment until NAAT results are available to guide pathogen-directed therapy based on local resistance data 1, 2
  • For patients with severe urethritis or inability to follow-up, initiate empirical treatment immediately, as recommended by the European Urology guidelines 2

Empirical Treatment Regimens (When Indicated)

  • For suspected gonococcal infection, the European Association of Urology guidelines recommend Ceftriaxone 1 g IM or IV single dose PLUS Azithromycin 1 g PO single dose 1, 2
  • For non-gonococcal urethritis (unidentified pathogen), the European Urology guidelines recommend Doxycycline 100 mg PO twice daily for 7 days 1, 2
  • For confirmed Chlamydia trachomatis, the European Urology guidelines recommend Azithromycin 1.0-1.5 g PO single dose OR Doxycycline 100 mg PO twice daily for 7 days 1

Critical Management Points

  • Sexual partners must be treated while maintaining patient confidentiality, as recommended by the European Association of Urology guidelines 1, 2, 3
  • Use pathogen-directed treatment based on local resistance data whenever possible, as recommended by the European Urology guidelines 1
  • Consider Mycoplasma genitalium in persistent cases, which may require moxifloxacin 400 mg daily for 7-14 days if macrolide resistance is present, as recommended by the European Urology guidelines 1, 3